| 2.85 -0.24 (-7.77%) | 06-01 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.27  |
1-year : | 4.99 |
| Resists | First : | 3.66 |
Second : | 4.28 |
| Pivot price | 3.29 |
|||
| Supports | First : | 2.66 |
Second : | 2.21 |
| MAs | MA(5) : | 3.08 |
MA(20) : | 3.43 |
| MA(100) : | 4.18 |
MA(250) : | 4.04 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 24.5 |
D(3) : | 24.6  |
| RSI | RSI(14): 27.7 |
|||
| 52-week | High : | 5.92 | Low : | 2.66 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SRTS ] has closed below the lower bollinger band by 6.9%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 26.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3 - 3.02 | 3.02 - 3.04 |
| Low: | 2.62 - 2.64 | 2.64 - 2.66 |
| Close: | 2.82 - 2.85 | 2.85 - 2.88 |
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Tue, 02 Jun 2026
Insiders Give Up US$51k As Sensus Healthcare Stock Drops To US$2.85 - simplywall.st
Wed, 20 May 2026
How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes - Yahoo Finance
Tue, 12 May 2026
Sensus Healthcare (SRTS) director Eric Sachetta adds 1,500 shares in open-market buy - Stock Titan
Fri, 08 May 2026
Sensus Healthcare Q1 Earnings Call Highlights - The Globe and Mail
Thu, 07 May 2026
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights - Business Wire
Thu, 23 Apr 2026
Sensus Healthcare (SRTS) director amends Form 4 to report spouse’s 2,093 shares - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 16 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 17.8 (%) |
| Held by Institutions | 29.4 (%) |
| Shares Short | 422 (K) |
| Shares Short P.Month | 395 (K) |
| EPS | -0.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.92 |
| Profit Margin | -28.1 % |
| Operating Margin | -63.8 % |
| Return on Assets (ttm) | -11.2 % |
| Return on Equity (ttm) | -14.9 % |
| Qtrly Rev. Growth | -62.3 % |
| Gross Profit (p.s.) | 0.72 |
| Sales Per Share | 1.66 |
| EBITDA (p.s.) | -0.61 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | 4 (M) |
| PE Ratio | -6.07 |
| PEG Ratio | 0 |
| Price to Book value | 0.97 |
| Price to Sales | 1.7 |
| Price to Cash Flow | 88.84 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|